Sciences and Regulatory Issues
Our science and regulatory affairs track will provide up-to-date insight and context to today’s developments and trends so you can better navigate the regulatory twists and turns for generic and biosimilar drug applications. You will hear from subject matter experts, engage with them and other experts from the FDA, industry, and academia, to better inform your business strategies and optimize your results.